No Data
No Data
Anhui Hongyu Wuzhou Medical Manufacturer: Summary of Half-Year Report in 2024.
Anhui Hongyu Wuzhou Medical Manufacturer: Half-year report for the year 2024.
Wuzhou Medical (301234.SZ) has released its performance for the first half of the year, with a net income of 21.7675 million yuan, a decrease of 39.86%.
Wuzhou Medical (301234.SZ) released its semi-annual report for 2024, during which the company achieved revenue...
Wuzhou Medical (301234.SZ): net income in the first half of the year was 21.7675 million yuan, a decrease of 39.86% year-on-year
On August 23, Gelonghui announced the semi-annual report of Wuzhou Medical (301234.SZ) for the year 2024, with a total operating income of 0.212 billion yuan for the reporting period, a year-on-year decrease of 23.32%; a net income attributable to the shareholders of the listed company of 21.7675 million yuan, a year-on-year decrease of 39.86%; a net income attributable to the shareholders of the listed company after deducting non-recurring gains and losses of 18.0883 million yuan, a year-on-year decrease of 48.20%; and a basic earnings per share of 0.3201 yuan.
Is It Worth Considering Anhui Hongyu Wuzhou Medical Manufacturer Co.,LTD. (SZSE:301234) For Its Upcoming Dividend?
Wuzhou Medical (301234.SZ) has been granted a patent for an intelligent, wearable, precision injector with delayed release.
On June 18th, Gelunhui reported that Wuzhou Medical (301234.SZ) obtained an invention patent certificate from the State Intellectual Property Office on June 18, 2024. The company's medical equipment product, "An intelligent wearable precision injector with delayed effect", has obtained the patent authorization. The product covered by this patent authorization is in the field of medical equipment technology. It is an innovative patch injection system designed to automatically deliver large doses or high viscosity biotech drugs subcutaneously in home or clinical environments. Its feature is that it can be done in seconds to a few minutes.
No Data
No Data